From: HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study
Characteristics | Persistence | Clearance | p | ||
---|---|---|---|---|---|
N = 80 | % | N = 71 | % | ||
Marital status | Â | Â | Â | Â | Â |
 Non-stable | 34 | 42.5 | 17 | 23.9 | <0.05* |
 Stable | 46 | 57.5 | 54 | 76.1 | |
Race/skin color | Â | Â | Â | Â | Â |
 White | 40 | 50.0 | 54 | 76.1 | <0.05 # |
 Brown | 24 | 30.0 | 13 | 18.3 | |
 Black | 16 | 20.0 | 4 | 5.6 | |
Years of education | Â | Â | Â | Â | |
 0-4 | 13 | 16.2 | 7 | 9.9 | 0.68# |
 5-8 | 31 | 38.8 | 30 | 42.2 | |
 >9 | 36 | 45.0 | 34 | 47.9 | |
Menarche (yrs.) | Â | Â | Â | Â | Â |
 <9 | 3 | 3.75 | 1 | 1.4 | 0.09# |
 9-15 | 74 | 92.5 | 61 | 85.9 | |
 >15 | 3 | 3.75 | 9 | 12.7 | |
Age at 1st sexual experience (yrs.) | Â | Â | Â | ||
 <16 | 54 | 67.5 | 39 | 54.9 | 0.19# |
 16-20 | 23 | 28.8 | 30 | 42.3 | |
 >20 | 3 | 3.7 | 2 | 2.8 | |
Age of 1st pregnancy (yrs.) | Â | Â | Â | Â | |
 <16 | 22 | 27.5 | 11 | 15.5 | 0.17* |
 16-20 | 38 | 47.5 | 36 | 50.7 |  |
 >20 | 20 | 25.0 | 24 | 33.8 |  |
Parity | Â | Â | Â | Â | Â |
 0 | 40 | 50.0 | 37 | 52.1 | 0.83# |
 1-3 | 38 | 47.5 | 30 | 42.3 | |
 ≥4 | 2 | 2.5 | 4 | 5.6 | |
Lifetime no. of sex partners | Â | Â | Â | Â | |
 ≤5 | 50 | 62.5 | 55 | 77.5 | 0.18# |
 6-10 | 14 | 17.5 | 10 | 14.1 | |
 11-20 | 10 | 12.5 | 4 | 5.6 | |
 >20 | 6 | 7.5 | 2 | 2.8 | |
Sex partners (last 12 mos.) | Â | Â | Â | ||
 <3 | 75 | 93.8 | 68 | 95.8 | 1.0# |
 ≥3 | 5 | 6.2 | 3 | 4.2 | |
HIV-positive status | 28 | 35.0 | 26 | 36.6 | 0.84* |
Smoking | 22 | 27.5 | 15 | 21.1 | 0.36* |
Drug use | Â | Â | Â | Â | Â |
 None | 59 | 73.8 | 59 | 83.1 | 0.39# |
 Marijuana | 14 | 17.5 | 10 | 14.1 | |
 Cocaine/crack | 7 | 8.7 | 2 | 2.8 | |
Alcohol | 15 | 18.8 | 5 | 7.0 | 0.053# |
Previous STD | 30 | 37.5 | 24 | 33.8 | 0.64* |
Sexual partner with STD 1 | 18 | 22.5 | 13 | 18.3 | 0.52* |
Mode of delivery | Â | Â | Â | Â | Â |
 Cesarean section | 37 | 46.2 | 27 | 38.0 | 0.33 |
 Vaginal | 43 | 53.8 | 44 | 62.0 | |
HPV infection type | Â | Â | Â | Â | Â |
 Subclinical/clinical | 60 | 75.0 | 51 | 71.8 | 0.66 |
 HPV-positive | 20 | 25.0 | 20 | 28.2 | |
HPV type | Â | Â | Â | Â | Â |
 High risk | 34 | 64.1 | 22 | 54.4 | 0.3 |
 Low risk | 19 | 35.9 | 20 | 47.6 |